Do emerging technologies such as regenerative medicine, nanotechnology and artificial intelligence ignite your intellectual curiosity? If so, you’ll definitely want to get involved with Medical Intelligence & Innovations Group (MI2), which meets monthly at CHOC Children’s.
This informal venue is open to the CHOC Children’s campus and affiliated medical community members interested in exchanging news, information or ideas concerning emerging medical technology and future trends in medicine. Specific areas of interest include genomic medicine, regenerative medicine, robotic surgery, nanotechnology and artificial intelligence.
Recent presentations and discussions have included:
- Artifical intelligence and human-computer interface
- Tissue engineering and “personalized” medicine
- Wireless tools, tests and apps bringing diagnostic information to the bedside
- Genome sequencing used to halt the recent MRSA outbreak
- Biocompatible hydrogels via dynamic optical projection stereolithography (DOPsL) biofabrications for regenerative medicine
- Transient/dissolvable electronics • Nanotechnology and glucose-powered fuel cells
- Nobel-winning work in stem cells, cell signaling and G protein-coupled receptors (GPCRs)
- Crowdfunding and other National Institute of Health (NIH)-funding alternatives
- Cyperspace security
Developed by CHOC physicians Anthony Chang, M.D., medical director, CHOC Children’s Heart Institute and Nick Anas, M.D., CHOC Children’s pediatrian-in-chief, MI2 is also studying how new technology is impacting the delivery of pediatric medicine.
“A sizable void exists in pediatric medicine in the areas of regenerative medicine, genomic medicine, robotic surgery, artificial intelligence, nanotechnology, biomedical informatics and decision support/outcomes analysis,” Dr. Chang said. “MI2 is an informal venue providing the hospital with a myriad of ideas regarding research and development in these key emerging areas, as well as other emerging technologies.”
MI2 Summer 2013 Internships Available
Three interns were selected for the inaugural MI2 2012 Summer Internship, where they had the opportunity to assist with projects, gain clinical exposure, and present research and topics at the monthly meetings. The first program of its kind in the nation, the MI2 Summer Internship Program is available for high school, undergraduate and graduate students.
Anthony Chang, MD MBA MPH
Pediatrics 2040: Future Trends and Emerging Innovations in the Next 25 Years
October 3 – 5, 2013
Disneyland Grand Californian Hotel® & Spa, Anahiem
The next 25 years are certain to completely transform medicine. “Pediatrics 2040” is the first meeting of its kind in the nation for physicians, healthcare administrators and other healthcare providers interested the impact of emerging technology and trends on the future delivery of pediatric healthcare.
In addition to the emerging areas – Regenerative Medicine, Genomic Medicine, Robotic Surgery, Artificial Intelligence and Nanotechnology, this comprehensive three-day conference covers:
- Healthcare policy and finance
- Innovative research
- Global health
- Pediatric epidemiology
- Healthcare delivery models
- Social media tools
- Computer technology
“Pediatrics 2040” is a partnership of CHOC Children’s, the University of California, Irvine, School of Medicine; and the American Academy of Pediatrics.
Curious to learn more? For more information about MI2 monthly meetings, “Pediatrics 2040” or how to support or recommend candidates for the 2013 internship program, please contact Anthony Chang, M.D., at email@example.com.